Cases 1 - 4 of 4
FTC v. Endo Pharmaceuticals Inc., et al
as 22-5137
Plaintiff / Appellant:
Federal Trade Commission
Defendant / Appellee:
Endo Pharmaceuticals Inc., Endo International PLC, Impax Laboratories, LLC, formerly known as IMPAX Laboratories, Inc. and others
FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC. et al
as 1:2021cv00217
Defendant:
AMNEAL PHARMACEUTICALS, INC, IMPAX LABORATORIES, LLC, ENDO INTERNATIONAL PLC and others
Plaintiff:
FEDERAL TRADE COMMISSION
Cause Of Action: 15 U.S.C. ยง 15
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7136
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellee:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant:
Cambrex Corporation and Gyma Laboratories of America, Inc.
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7135
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellant:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee:
Cambrex Corporation and Gyma Laboratories of America, Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
